What is the size of the South Korea AI Medical Devices and SaMD Market?

The South Korea AI Medical Devices and SaMD Market was valued at approximately USD 682 Million. It is projected to grow at a CAGR of around 18.5% during the forecast period of 2026–2030, reaching an estimated USD 1593.59 Million by 2030.

What are the South Korea AI Medical Devices and SaMD Market Drivers?

Ans. The major drivers of the South Korea AI Medical Devices and SaMD Market include the increasing adoption of intelligent workflow automation across healthcare institutions, growing digital transformation initiatives within the healthcare sector, and rising demand for predictive and proactive care models. Healthcare providers are increasingly deploying AI-powered medical technologies to enhance diagnostic accuracy, improve clinical decision-making, streamline operational workflows, and optimize resource utilization. Additionally, expanding healthcare digitization, increasing demand for interoperable solutions, and the need to address workforce constraints while improving care delivery efficiency continue to support market growth across South Korea.

What are the segments under the South Korea AI Medical Devices and SaMD Market by Product Type, Clinical Specialty, Deployment Model, End User, Regulatory Classification, and Region?

Ans. AI Medical Imaging Software, AI Clinical Decision Support Software, AI Diagnostic & Screening Software, AI Monitoring & Predictive Analytics Software, AI-Enabled Medical Devices, and Others are the segments under the South Korea AI Medical Devices and SaMD Market by Product Type. Radiology, Cardiology, Oncology, Neurology, Ophthalmology, Pathology, and Others are the segments by Clinical Specialty. Cloud-Based, On-Premise, and Hybrid Deployment are the segments by Deployment Model. Tertiary & General Hospitals, Specialty Hospitals, Diagnostic Imaging Centers, Clinics & Physician Practices, Academic & Research Institutions, and Others are the segments by End User. AI-Based Diagnostic SaMD, AI-Based Detection & Triage SaMD, AI-Based Monitoring SaMD, AI-Enabled Medical Devices, and Others are the segments by Regulatory Classification. Seoul Metropolitan Area, Gyeonggi Province, and Remaining South Korea Regions are the regional segments under the South Korea AI Medical Devices and SaMD Market.

Which is the most dominant region for the South Korea AI Medical Devices and SaMD Market?

The Seoul Metropolitan Area is the most dominant region in the South Korea AI Medical Devices and SaMD Market, supported by its concentration of advanced healthcare infrastructure, leading academic medical centers, strong digital health ecosystems, and extensive commercialization activities for AI-enabled healthcare technologies. Gyeonggi Province is expected to be the fastest-growing region during the forecast period of 2026–2030, driven by increasing healthcare technology investments, expanding innovation clusters, and growing adoption of AI-powered medical solutions. The remaining regions across South Korea continue to witness steady growth due to ongoing healthcare modernization efforts and broader deployment of AI-based clinical technologies.

Which Companies are key players in the South Korea AI Medical Devices and SaMD Market?

The key players in the South Korea AI Medical Devices and SaMD Market include Lunit Inc., VUNO Inc., JLK Inc., Coreline Soft Co., Ltd., Samsung Medison Co., Ltd., Deep Bio Inc., Neurophet Inc., Kakao Healthcare Corporation, MEDICAL IP Co., Ltd., Mediwhale Inc., SK Telecom Co., Ltd., Heuron Co., Ltd., SEERS Technology Inc., Siemens Healthineers Korea, and GE HealthCare Korea.

South Korea AI Medical Devices and SaMD Market | Size, Overview, Trends & Forecast 2026

South Korea AI Medical Devices and SaMD Market Research Report – Segmented by Product Type (AI Medical Imaging Software, AI Clinical Decision Support Software, AI Diagnostic & Screening Software, AI Monitoring & Predictive Analytics Software, AI-Enabled Medical Devices, Others); by Clinical Speciality (Radiology, Cardiology, Oncology, Neurology, Ophthalmology, Pathology, Others); by Deployment Model (Cloud-Based, On-Premise, Hybrid Deployment); by End User (Tertiary & General Hospitals, Specialty Hospitals, Diagnostic Imaging Centers, Clinics & Physician Practices, Academic & Research Institutions, Others); by Regulatory Classification (AI-Based Diagnostic SaMD, AI-Based Detection & Triage SaMD, AI-Based Monitoring SaMD, AI-Enabled Medical Devices, Others) ; and Region - Size, Share, Growth Analysis | Forecast (2026– 2030)

Published: 2026 - Jun

Report Code: VMR-19443

Region: Asia Pacific

Historic Range: 2023-2025

Forecast: 2026-2032

Format: Excel and PDF

❓ Enquire Before Buying

Fill out the form below and our team will get back to you shortly

The field with (*) is required.

📋 Contact Information

Name *

Email *

Company *

Job Title *

Country *

Phone *

Message (Optional)

Security Verification

This form is protected by Google reCAPTCHA v3. Verification runs automatically when you submit.

Your information is secure and will not be shared with third parties.

Select User License Type

Data Spreadsheet: Market data delivered in spreadsheet format for analysis.

Single User: One named user; PDF report access for internal use.

Multi User: Up to five users within the same organization at one location.

Corporate User: Enterprise-wide access across your organization.

Data Spreadsheet

2500

Single User

3400

Multi User

3900

Corporate User

4600

Country-Specific Report

Dive into Country Outlook

Unlock Country Level Outlook, Trends, Cross-country Comparability, or supply Chain Variations.

Access Country Insights

Testimonials

“We received a complex piece of work for our niche market from Virtue Market research in short period of time. I appreciate the quality and content of the final files we received. Thanks for the support”

Medical Devices Company based in Europe